Understanding Your AML Journey Starts Here
When facing acute myeloid leukaemia, having the right information can make all the difference. Our Oncomine AML Panel Test provides the genetic clarity you and your healthcare team need to make informed treatment decisions. We understand the anxiety and uncertainty that comes with an AML diagnosis, which is why we’ve made this comprehensive genetic testing accessible across South Africa.
What This Test Reveals About Your AML
The Oncomine AML Panel uses advanced next-generation sequencing technology to analyse over 45 cancer-related genes and fusion genes associated with acute myeloid leukaemia. This isn’t just a simple blood test – it’s a detailed genetic map that helps identify the specific mutations driving your condition. By understanding your unique genetic profile, your medical team can recommend treatments that are more likely to be effective for your specific type of AML.
Who Should Consider This Test?
This test is particularly important if you:
- Have been recently diagnosed with acute myeloid leukaemia
- Are experiencing unexplained fatigue, frequent infections, or unusual bruising
- Have a family history of blood cancers
- Are not responding as expected to current AML treatments
- Want to explore targeted therapy options based on your genetic profile
Early genetic profiling can significantly impact your treatment success and quality of life.
Why Genetic Testing Matters for Your AML Treatment
Knowing your genetic mutations helps your healthcare team:
- Select targeted therapies that work specifically against your cancer’s genetic drivers
- Avoid treatments that are unlikely to be effective for your mutation profile
- Monitor treatment response more accurately
- Identify potential clinical trial opportunities
- Make more informed decisions about transplant eligibility and timing
This personalised approach can lead to better outcomes and fewer side effects.
Understanding Your Test Results
Your results will be carefully explained by our genetic specialists and shared with your treating physician. We provide:
- Clear identification of any genetic mutations found
- Interpretation of what these mutations mean for your treatment
- Recommendations for targeted therapy options
- Guidance on next steps in your care journey
Remember, genetic information is powerful – it gives you and your medical team the knowledge to fight AML more effectively.
Transparent Pricing – No Hidden Costs
| Test Option | Price | Savings |
|---|---|---|
| Regular Price | ZAR 15,200 | – |
| Special Price | ZAR 13,650 | ZAR 1,550 |
This comprehensive genetic analysis represents excellent value compared to the cost of ineffective treatments or delayed care.
Why Trust Oracle Genomics?
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Analysis: Results interpreted by experienced haematologists and genetic specialists
- Fast Turnaround: Results typically available within 15 days of sample receipt
- Proven Accuracy: Next-generation sequencing technology ensures reliable results
- Patient-Focused: We understand the emotional journey of cancer diagnosis
Take Control of Your AML Treatment Today
Don’t let uncertainty dictate your treatment path. With our Oncomine AML Panel Test, you gain the genetic insights needed for personalised care. Our team is here to support you every step of the way.
Important Note: Samples must reach us by the 1st or 16th of each month, with results available on the 15th or 30th of the same month. A duly filled NGS Test Requisition Form (Form 40) is mandatory for processing.
Your journey to personalised AML care starts with one decision. Book your test today and take the first step toward targeted, effective treatment.
